Group 1 - The company has completed the issuance of the second phase of technology innovation bonds for the year 2025, with a registered amount of RMB 40 billion, valid for two years from March 20, 2025 [1][2] - The first phase of medium-term notes was issued in April 2025, totaling RMB 5 billion [1] - The company’s affiliate, Fosun United Health Insurance Co., Ltd., participated in the subscription of the second phase of debt financing tools, with a final allocation of RMB 30 million [1] Group 2 - On August 7, 2025, the company’s subsidiary, Nantong Jianjia, signed a loan agreement with Nantong Rural Commercial Bank for RMB 20 million, with a loan term from July 23, 2025, to December 21, 2028 [6] - The company provided a joint liability guarantee for the loan, with a guarantee period of three years after the loan repayment deadline [6][10] - The company has approved a total guarantee limit of RMB 35,048 million, which includes guarantees for its subsidiaries [11][30] Group 3 - As of August 8, 2025, the total amount of external guarantees provided by the group is approximately RMB 23,930 million, accounting for 50.64% of the net assets attributable to shareholders as of December 31, 2024 [30] - There are no overdue guarantee matters as of the same date [31]

Group 1 - The company has completed the issuance of the second phase of technology innovation bonds for the year 2025, with a total registered amount of RMB 40 billion, valid for two years from March 20, 2025 [1][2] - The first phase of medium-term notes was issued in April 2025, totaling RMB 5 billion [1] - The company’s affiliate, Fosun United Health Insurance Co., Ltd., participated in the subscription of the second phase of debt financing tools, with a final allocation amount of RMB 30 million [1] Group 2 - On August 7, 2025, the company’s subsidiary, Nantong Jianjia, signed a loan agreement with Nantong Rural Commercial Bank for RMB 20 million, with a loan term from July 23, 2025, to December 21, 2028 [6] - The company provided a joint liability guarantee for the loan, with a guarantee period of three years after the debt performance period [6][12] - The company has also signed several guarantee contracts for its subsidiaries, including a maximum joint liability guarantee for RMB 5.5 million and RMB 11 million for other subsidiaries [7][19] Group 3 - As of August 8, 2025, the total external guarantee amount by the group is approximately RMB 23.93 billion, accounting for 50.64% of the net assets attributable to shareholders as of December 31, 2024 [31] - There are no overdue guarantee matters as of the same date [31]

Group 1 - The company provided a guarantee for its wholly-owned subsidiary, Mosi International Holdings Limited, to meet its financing needs, with a total guarantee amount not exceeding RMB 4 billion [2][5] - The internal decision-making process for the guarantee was approved in meetings held on April 24, 2025, and May 16, 2025, by the board of directors and the annual general meeting [2][3] - The guarantee is within the approved limit and does not require additional internal decision-making procedures [3] Group 2 - Mosi International Holdings Limited, established on October 13, 2017, is a wholly-owned subsidiary of the company, with a registered capital of RMB 100 million [4] - The company holds 100% equity in Mosi International, which has a good credit status and is not a defaulter [4][5] - The guarantee provided by the company covers all debts incurred by Mosi International under the credit agreement with China Everbright Bank [5] Group 3 - The total amount of guarantees provided by the company to its wholly-owned subsidiaries after this guarantee will be RMB 1.68 billion, accounting for 37.19% of the company's audited net assets for 2024 [5] - The balance of guarantees to wholly-owned subsidiaries will be RMB 1.0406115 billion, accounting for 23.03% of the company's audited net assets for 2024 [5] - As of the announcement date, the company and its wholly-owned subsidiaries have no guarantees provided to entities outside the consolidated financial statements, nor any overdue debts related to guarantees [5] Group 4 - The company has initiated a share repurchase plan to address its equity distribution issue, with a total repurchase amount between RMB 12 million and RMB 24 million [7][8] - As of July 18, 2025, the company has repurchased 4,265,977 shares, accounting for 1.07% of the total share capital before the repurchase [8][9] - The company plans to complete the capital reserve transfer to increase share capital by August 21, 2025, to meet listing conditions [10][11]

Group 1 - The company has signed a maximum guarantee contract with Industrial Bank Co., Ltd. Wenzhou Branch to provide a joint liability guarantee for a bank credit limit of 44 million yuan for its wholly-owned subsidiary, Zhejiang Fuda Alloy Material Technology Co., Ltd. [2][4] - The guarantee period is three years from the expiration of the debt performance period under the main contract [7][11]. - The company has approved a total credit limit of up to 2.8 billion yuan for 2025, which can be used for mutual guarantees among the company and its subsidiaries [3][12]. Group 2 - As of the announcement date, the total guarantee balance for the company and its subsidiaries is 1.2201591 billion yuan, accounting for 125.67% of the latest audited net assets [13]. - The total guarantee amount is 1.969 billion yuan, which represents 202.80% of the latest audited net assets [13]. - All guarantees provided are for wholly-owned subsidiaries, and there are no overdue guarantees [13].

Group 1 - The company has approved a guarantee for its wholly-owned subsidiary, Shenzhen Koodong Digital Co., Ltd., to apply for a credit sales limit of RMB 450 million from the supplier, Shanghai Ingram Logistics Co., Ltd. [1][3] - The guarantee will be provided at a 100% shareholding ratio, with the total guarantee amount being RMB 450 million [1][3] - Koodong Digital will act as both the guaranteed party and the counter-guaranteeing party, providing a joint liability guarantee to the company [1][3] Group 2 - As of December 31, 2024, Koodong Digital had total assets of RMB 1.53192 billion, total liabilities of RMB 996.8803 million, and net assets of RMB 535.04 million [2] - For the year 2024, Koodong Digital achieved operating revenue of RMB 5.8984016 billion and a net profit of RMB 89.7632 million [2] - As of March 31, 2025, Koodong Digital's total assets were RMB 1.1931982 billion, total liabilities were RMB 636.1788 million, and net assets were RMB 557.0194 million [3] Group 3 - The guarantee agreement has not yet been signed, and the actual guarantee amount will be disclosed according to the supplier's approved credit sales limit [3][4] - If Koodong Digital fails to repay the principal and interest, it must repay the company within 10 working days after the company settles the debt with the creditor [4] - The increase in the guarantee is expected to help Koodong Digital quickly open sales channels for NPP products and generate sales revenue [4][6] Group 4 - As of the announcement date, the company's total expected guarantee amount is RMB 14.3165 billion, including the new guarantee of RMB 450 million [4] - The total balance of external guarantees by the company and its subsidiaries is RMB 1.755 billion, accounting for 28.69% of the company's latest audited net assets [4]

在上述授信期限内，如公司单笔授信的存续期超过了决议和授权的有效期，则决议 和授权的有效期自动顺延至该笔授信终止时止。 证券代码：688622 证券简称：禾信仪器 公告编号：2025-043 广州禾信仪器股份有限公司 关于公司及子公司申请综合授信额度并提供担保及接受 关联方担保的公告 为保证上述综合授信融资业务的顺利实施，根据公司及全资子公司的日常经营和业 务发展的资金需求，公司在确保规范运作和风险可控的前提下，公司及全资子公司昆山 禾信拟以包括但不限于银行承兑票据、商业承兑票据、土地、房产、设备、专利等资产 为自身融资业务提供担保，预计 2025 年度担保总额不超过人民币 12,000 万元。上述担 保仅限于全资子公司为公司担保等，不包括公司为全资子公司昆山禾信提供担保，以及 公司及全资子公司为合并报表范围以外的主体提供担保。担保形式包括但不限于保证、 抵押、质押等相关法律法规规定的担保类型，实际提供担保的金额根据公司实际获得的 授信额度确定。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、事项概述 (一)2025 ...

Group 1 - The company provided a guarantee for its subsidiary, Shuangqian Industry, to support its daily operations and business development needs, with a maximum guarantee amount of RMB 19 million [1][4] - The guarantee was approved during the company's board meeting and annual shareholders' meeting, allowing for a total credit limit of up to RMB 5 billion for 2025, with a maximum guarantee amount of RMB 2.5 billion [2][5] - The company has a total external guarantee balance of RMB 401.82 million, which is 6.67% of its audited net assets for 2024, with no overdue guarantees reported [7] Group 2 - The company initiated a share repurchase plan, allowing for the buyback of shares at a price not exceeding RMB 3.80 per share, with a total repurchase amount between RMB 300 million and RMB 500 million [11] - As of July 31, 2025, the company had repurchased a total of 109.86 million shares, representing 3.32% of its total share capital, with a total payment of approximately RMB 277.30 million [12] - The company will continue to comply with relevant regulations and disclose progress on the share repurchase in a timely manner [13]

Summary of Key Points Core Viewpoint - The company, New Mile Health Technology Group Co., Ltd., has approved a total guarantee amount of RMB 1.814 billion for its subsidiaries to secure credit facilities from financial institutions over the next 12 months [2][3]. Group 1: Guarantee Overview - The company held a board meeting on April 28, 2025, and a shareholder meeting on May 19, 2025, to approve the guarantee for its subsidiaries [2]. - The total guarantee amount approved is RMB 181,400 million [2]. - The company has provided joint liability guarantees for its subsidiaries, including Siyang Hospital and Ganxi Hospital, to secure loans from local banks [3][4]. Group 2: Financial Status of Guaranteed Entities - Siyang Hospital has a registered capital of RMB 343.992 million and is a wholly-owned subsidiary of the company, holding 84.80% of its shares [4][6]. - As of March 31, 2025, Siyang Hospital's total assets were RMB 972.998 million, with total liabilities of RMB 876.711 million [5]. - Ganxi Hospital, another subsidiary, has a registered capital of RMB 18.75 million and is also a controlled subsidiary, with the company holding 84.83% of its shares [6][7]. Group 3: Guarantee Contracts - The company has signed a maximum guarantee contract with Siyang Rural Commercial Bank for a loan amount of RMB 29.5 million for Siyang Hospital [7]. - A similar guarantee contract has been signed with Jiujiang Bank for a maximum amount of RMB 15 million for Ganxi Hospital [7]. - The guarantee period for both contracts is set for three years [7]. Group 4: Board Opinion and Risk Management - The board believes that both Siyang Hospital and Ganxi Hospital are operating well, and the company can fully manage their financial conditions [8]. - The financial risks associated with the guarantees are considered manageable and will not harm the interests of the company and its shareholders [8]. - As of June 30, 2025, the total actual guarantee balance for subsidiaries was RMB 702.4665 million, accounting for 35.39% of the company's latest audited net assets [9].

Overview - The company, Bluestar Medical Co., Ltd., plans to apply for a total credit limit of up to RMB 1.71 billion for 2025, which includes various types of financing such as working capital loans and bank guarantees [1][3] Credit and Guarantee Situation - The company and its subsidiaries will provide guarantees totaling no more than RMB 1.71 billion, with RMB 1.544 billion allocated for subsidiaries with a debt-to-asset ratio below 70% and RMB 166 million for those at or above 70% [1][3] - The guarantee period is valid for 12 months from the date of the shareholders' meeting resolution [1] Recent Developments - Recently, the company applied for a credit limit of up to RMB 50 million from Zheshang Bank, securing it with a pledge of a RMB 50 million time deposit [3][7] - This guarantee does not exceed the approved limit from the recent board and shareholders' meetings, thus no additional meetings are required for approval [3] Financial Data - As of the announcement date, the total maximum guarantee amount for the company and its subsidiaries is RMB 3,803.58 million, which accounts for 46.46% of the company's audited net assets for 2024 [8] - The company has no overdue guarantees or any litigation related to guarantees [9] Company Information - Bluestar Medical Co., Ltd. was established on December 2, 2002, with a registered capital of RMB 1,007.13 million [4][5] - The company specializes in the production of PVC gloves, nitrile gloves, and various medical devices [5]

证券代码：603139 证券简称：康惠制药 公告编号：2025-043 陕西康惠制药股份有限公司 关于为控股子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 担保对象及基本情况 （一）担保的基本情况 二、被担保人基本情况 （一）基本情况 ■ ● 累计担保情况 ■ 一、担保情况概述 ■ 三、担保协议的主要内容 1、保证合同 保证人：陕西康惠制药股份有限公司 2024年7月，贵阳银行股份有限公司成都都江堰支行（以下简称"贵阳银行"）向四川春盛药业集团股份 有限公司（以下简称"春盛药业"）提供借款500万元人民币，该笔借款将于2025年7月31日到期，公司作 为担保方，为该笔借款提供连带责任保证【具体内容详见公司于2024年8月1日在上海证券交易所网站 （www.sse.com.cn)披露的2024-036号公告】。近期，春盛药业就该笔借款申请了续贷，并于2025年7月 29日，与贵阳银行签署《流动资金借款合同》，借款期限自2025年7月30日至2026年7月12日止。公司与 贵阳银行签署《保 ...